Condition
Safety Issues clinical trials and research
As of November 12, 2026, Find a Trial lists 13 Safety Issues clinical trials that are recruiting, at sites in 11 countries (most in Poland (4), China (4), Afghanistan (1)). By phase: Phase 4 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 13Clinical trials
- 11Countries
Newest Safety Issues clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| SSS55 safety and how the body handles it in healthy adults | Phase 1 | Shanghai, Shanghai Municipality | Recruiting | Jul 10, 2025 |
| Be SMART secure firearm storage counseling for hospitalized caregivers | — | Aurora, Colorado and 1 other locations | Recruiting | Jul 3, 2024 |
| Registry for patients undergoing coronary intervention with orbital atherectomy | — | Legnica, Lower Silesian Voivodeship and 1 other locations | Recruiting | Jun 11, 2024 |
| Evaluation of a new bone graft substitute for tooth extraction sites | — | Louvain-la-Neuve, Brabant Wallon and 4 other locations | Recruiting | Apr 25, 2024 |
| Registry for patients with refractory angina undergoing Coronary Sinus Reducer implantation | — | Lubin, Lower Silesian Voivodeship and 1 other locations | Recruiting | Mar 1, 2024 |
| Evaluating bifurcation coronary interventions using two techniques | — | Legnica, Lower Silesian Voivodeship and 1 other locations | Recruiting | Feb 28, 2024 |
| Evaluating the impact of pain management on patients' lives | — | Surrey, British Columbia | Recruiting | Oct 10, 2023 |
| Registry of patients undergoing coronary interventions with shockwave therapy | — | Legnica, Lower Silesian Voivodeship and 1 other locations | Recruiting | Jun 23, 2023 |
| Switching to Tenofovir Alafenamide for Chronic Hepatitis B Treatment | — | Taichung, Taiwan | Recruiting | Oct 17, 2022 |
| Comparing two treatments for femoropopliteal artery disease | — | Beijing | Recruiting | Aug 26, 2022 |
All recruiting trials (13)
-
SSS55 safety and how the body handles it in healthy adults
This trial tests a single injection of SSS55 in healthy adults to see if it is safe, how the body processes it, and whether it triggers immune responses.
-
Be SMART secure firearm storage counseling for hospitalized caregivers
This program will test whether a short Be SMART video and handout help caregivers of hospitalized children store firearms more safely at home.
-
Registry for patients undergoing coronary intervention with orbital atherectomy
This study is collecting information on patients with hard-to-treat heart blockages who are getting a specific procedure called orbital atherectomy to see how safe and effective it is.
-
Evaluation of a new bone graft substitute for tooth extraction sites
This study is testing a new bone graft substitute called Wishbone HA to see if it works as well as a standard option for helping people heal after tooth extractions.
-
Registry for patients with refractory angina undergoing Coronary Sinus Reducer implantation
This study is testing if a new device called the Coronary Sinus Reducer can help people with severe chest pain who haven't found relief from other treatments.
-
Evaluating bifurcation coronary interventions using two techniques
This study looks at how well two different stenting techniques work for patients with heart artery blockages to see which one is safer and more effective.
-
Evaluating the impact of pain management on patients' lives
This study looks at how pain management services can improve the lives of adults with chronic pain by checking their health, social life, and job situation.
-
Registry of patients undergoing coronary interventions with shockwave therapy
This study is collecting information on patients with hard blockages in their heart arteries who are getting a new shockwave treatment to see how safe and effective it is.
-
Switching to Tenofovir Alafenamide for Chronic Hepatitis B Treatment
This study is testing if switching chronic hepatitis B patients from their current medication to a new one called tenofovir alafenamide can make them happier with their treatment and help them stick to it better.
-
Comparing two treatments for femoropopliteal artery disease
This study tests whether a special balloon treatment or a stent works better for people with blocked arteries in their legs.
-
Empagliflozin with or without metformin for safety and tolerability in adults with Type 2 diabetes
This project will try empagliflozin, with or without metformin, in adults with Type 2 diabetes to see if it is safe and well tolerated in routine clinical care at participating centers.
-
Evaluating endovascular treatment for blood clots in the legs
This study is testing new treatments for blood clots in the legs to see if they are safe and effective for patients with certain types of blockages.
-
Reducing antibiotic use for patients with neutropenic fever after stem cell transplantation
This study is testing if stopping antibiotics early is safe for patients with neutropenic fever after stem cell transplantation who have been fever-free for 72 hours.
Related topics
Quick answers
How many Safety Issues clinical trials are recruiting right now?
13, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 11 countries. The most sites are in Poland (4 trials), China (4 trials), Afghanistan (1 trial), Kenya (1 trial), Nigeria (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.